These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16828897)

  • 1. Decompensated heart failure and cachexia: Is it time to legalize anabolics?
    Filippatos G; Rauchhaus M; Anker SD
    Int J Cardiol; 2006 Jul; 111(1):185-6. PubMed ID: 16828897
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac cachexia: a systematic overview.
    von Haehling S; Lainscak M; Springer J; Anker SD
    Pharmacol Ther; 2009 Mar; 121(3):227-52. PubMed ID: 19061914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference.
    von Haehling S; Stepney R; Anker SD
    Int J Cardiol; 2010 Oct; 144(3):347-9. PubMed ID: 20561693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic steroids.
    Treat Rev; 1995 May; (no 18):8. PubMed ID: 11362596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.
    von Haehling S; Doehner W; Anker SD
    Cardiovasc Res; 2007 Jan; 73(2):298-309. PubMed ID: 17034772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anabolic steroid available again.
    Posit Aware; 1996; 7(2):5. PubMed ID: 11363362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting.
    Gullett NP; Hebbar G; Ziegler TR
    Am J Clin Nutr; 2010 Apr; 91(4):1143S-1147S. PubMed ID: 20164318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia.
    Wilkes EA; Freeman JG
    Aliment Pharmacol Ther; 2006 Feb; 23(3):445-6; author reply 446-7. PubMed ID: 16423004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anabolic agents in the therapy of chronic circulatory failure].
    Bondarenko IP
    Vrach Delo; 1982 Sep; (9):52-5. PubMed ID: 6758353
    [No Abstract]   [Full Text] [Related]  

  • 10. New treatment available for AIDS cachexia.
    Hoyt G
    Surviv News (Atlanta Ga); 2003; ():7. PubMed ID: 14666919
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of end-stage cardiac failure with growth hormone.
    O'Driscoll JG; Green DJ; Ireland M; Kerr D; Larbalestier RI
    Lancet; 1997 Apr; 349(9058):1068. PubMed ID: 9107248
    [No Abstract]   [Full Text] [Related]  

  • 12. Anabolic steroids in the management of chronic wasting diseases.
    Wewalka FG
    J Am Med Womens Assoc; 1968 Apr; 23(4):339-45. PubMed ID: 4231281
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth failure in cystic fibrosis: a true need for anabolic agents?
    Colombo C; Battezzati A
    J Pediatr; 2005 Mar; 146(3):303-5. PubMed ID: 15756206
    [No Abstract]   [Full Text] [Related]  

  • 14. [Growth hormone--new therapy in heart failure?].
    Ben-Gal T; Adler Y; Battler A
    Harefuah; 2000 Jun; 138(12):1070-4. PubMed ID: 10979437
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone treatment in chronic heart failure: lessons from the first 99 patients.
    Cicoira M; Coats AJ; Anker SD
    Eur Heart J; 1998 Nov; 19(11):1605-7. PubMed ID: 9857911
    [No Abstract]   [Full Text] [Related]  

  • 16. [Are there premises to supplement testosterone in men with chronic heart failure?].
    Maj J; Jankowska EA; Banasiak W; Ponikowski P
    Kardiol Pol; 2008 Jan; 66(1):86-90. PubMed ID: 18266193
    [No Abstract]   [Full Text] [Related]  

  • 17. Who needs growth hormone therapy? Growth hormone helps some, but its use as an "anti-aging" agent is dubious.
    Frohman LA
    Health News; 2002 Oct; 8(10):4. PubMed ID: 12416482
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical assessment of the use of strophanthin and Nerobol in cardiac insufficiency].
    Polishchuk MA
    Klin Med (Mosk); 1970 Feb; 48(2):53-6. PubMed ID: 5425983
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure.
    Chaggar PS; Malkin CJ; Shaw SM; Williams SG; Channer KS
    Cardiovasc Ther; 2009; 27(3):187-93. PubMed ID: 19689618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human pharmacological study of quinbolone. Clinical and laboratory investigations of the effects of anabolic treatment in aged women].
    Mezzena R; Foresti M; Trisotto M; Bruni G
    G Gerontol; 1972 Apr; 20(4):361-78. PubMed ID: 5042390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.